Werkgroep Cardiologische centra Nederland

CHF fase I BMS (Completed)

A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986224 in Healthy Subjects and Chronic HFrEF
Medicine
BMS-986224
Population
Heart failure
Phase
Ib
Starting year
2017